Why so many sites? Is enrollment really so slow that RVV needs 50 sites to recruite the remaining < 800 patients?
That is just 16 patients per site?
I asked MF if the dose had been decided and he had no comment, sadly.
The interim data must have a setpoint, 400? RVV would need to complete that enrollment, plus 28 days for the course of treatment, plus data collection. It would seems that 60 days minimum would be needed.
-->Has the 400 been reached and they are collected data? Are they collected data as they go?
--->What is the driver for the added sites, the study was initially 10 sites.
The trial would\will be put to rest if the interim data is not good. Why spend funds to add sites unless some glimmer of response has been seen. It points to positivity.
This company is a major player in the Psilocybin market, that will be enough to support any investment at this level and drive it back to near or more than a dollar on any market hype around Psilocybin. In the past 2 weeks while the PSYK index took a beating RVV has stayed reasonably afloat. When it recovers RVV will lead the group.